May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Single-Dose Treatment With Dexamethasone Phosphate Resolves Concanavalin A-Induced Dry Eye in Rabbits
Author Affiliations & Notes
  • T. D. Blalock
    EyeGate Pharmaceuticals, Inc., Waltham, Massachusetts
  • R. Gee
    EyeGate Pharmaceuticals, Inc., Waltham, Massachusetts
  • M. Manzo
    EyeGate Pharmaceuticals, Inc., Waltham, Massachusetts
  • B. Ruiz-Perez
    EyeGate Pharmaceuticals, Inc., Waltham, Massachusetts
  • E. Skokanova
    EyeGate Pharmaceuticals, Inc., Waltham, Massachusetts
  • S. Rao
    Chicago Eye Institute, Chicago, Illinois
  • Footnotes
    Commercial Relationships  T.D. Blalock, EyeGate Pharmaceuticals, Inc., E; R. Gee, EyeGate Pharmaceuticals, Inc., E; M. Manzo, EyeGate Pharmaceuticals, Inc., E; B. Ruiz-Perez, EyeGate Pharmaceuticals, Inc., E; E. Skokanova, EyeGate Pharmaceuticals, Inc., E; S. Rao, EyeGate Pharmaceuticals, Inc., C.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 98. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      T. D. Blalock, R. Gee, M. Manzo, B. Ruiz-Perez, E. Skokanova, S. Rao; Single-Dose Treatment With Dexamethasone Phosphate Resolves Concanavalin A-Induced Dry Eye in Rabbits. Invest. Ophthalmol. Vis. Sci. 2008;49(13):98. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Current treatment options for dry eye syndrome include multiple doses of topical anti-inflammatory drugs. To evaluate the effectiveness of a single iontophoretic dose of a corticosteroid for treating Concanavalin A (Con A) induced dry eye in rabbits.

Methods: : 300 µg of Con A or saline were injected into the lacrimal glands of white New Zealand rabbits to induce inflammation, which is a well-established model of dry eye syndrome. 48 hours after Con A injection, the rabbits received a single iontophoretic dose of dexamethasone phosphate or saline using the EyeGate II device; a 3 mA current was applied for 5 minutes. The tear flow was measured with Schrimer strips and ocular surface damage was assessed by fluorescein staining followed by slit lamp microscopy. As indicators of inflammation, interleukin-1-beta (IL-1β) and transforming growth factor beta-1 (TGF-β1) in the lacrimal gland and cornea of rabbits were measured by ELISA.

Results: : Injection of Con A into the lacrimal gland of rabbit eyes significantly decreased tear volumes, substantially increased ocular surface damage for up to 8 days when compared to animals injected with saline, and significantly increased IL-1β and TGF-β1 production in the lacrimal glands at the two measured time points (days 4 and 8) post Con A injection. A single iontophoretic dose of dexamethasone phosphate 48 hours after Con A injection significantly increased tear volume and reduced ocular surface damage when compared to control animals that received Con A injection and iontophoretic treatment with saline. In addition, the single iontophoretic dose of dexamethasone phosphate decreased IL-1β 2.5-fold and TGF-β1 1.5-fold in the lacrimal glands 48 hours post treatment when compared to rabbits treated with an iontophoretic dose of saline.

Conclusions: : These data indicate that a single iontophoretic administration of dexamethasone phosphate significantly reduces lacrimal gland inflammation and the symptoms associated with Con A induced dry eye in rabbits.

Keywords: cornea: tears/tear film/dry eye • corticosteroids • lacrimal gland 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×